0 references
Altered Immune Profiles in Non‐Failing Heart Donors With Induced Long QT Syndrome: A Potential Risk Factor for Cardiac Allograft Vasculopathy
Clinical Transplantation2025Vol. 39(8), pp. e70286–e70286
Abstract
Neuro-immune dysregulation and integrin signaling related T cell activation underlie iLQTS-related heart donors. Targeting neuronal-integrin crosstalk may reduce CAV progression and improve transplant outcomes.
Related Papers
- → Current diagnostic and treatment strategies for cardiac allograft vasculopathy(2015)15 cited
- → Does heart rate predict allograft vasculopathy in heart transplant recipients?(2009)14 cited
- → Resting heart rate: A predictor of graft vasculopathy? Reply(2009)
- → Is First-year DSA After Heart Transplantation Truly a Biomarker for the Development of Cardiac Allograft Vasculopathy?(2018)
- → Heart failure hospitalization in adult patients with congenital heart disease: risk factors for repeated admissions(2021)